Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generics, Bulk Business Get Additional Attention From Wholesalers

Executive Summary

The "big three" wholesalers are looking to additional avenues for increasing profitability in their pharmaceutical distribution business following the adoption of fee-for-service agreements with brand manufacturers

You may also be interested in...



Wal-Mart Discount Drug Program Casts Shadow Over Generic Supply Chain

Wal-Mart's recent decision to offer a set, low price for a number of generic products could have significant negative business implications for the entire generic pharmaceutical supply chain

Wal-Mart Discount Drug Program Casts Shadow Over Generic Supply Chain

Wal-Mart's recent decision to offer a set, low price for a number of generic products could have significant negative business implications for the entire generic pharmaceutical supply chain

Wholesalers Beginning To Maximize Value Of Fee-For-Service Deals

As AmerisourceBergen gains more experience with its fee-for-service distribution contracts with manufacturers, the firm is beginning to maximize the potential value of the agreements

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel